Cargando…
Francisella Tularensis Blue–Gray Phase Variation Involves Structural Modifications of Lipopolysaccharide O-Antigen, Core and Lipid A and Affects Intramacrophage Survival and Vaccine Efficacy
Francisella tularensis is a CDC Category A biological agent and a potential bioterrorist threat. There is no licensed vaccine against tularemia in the United States. A long-standing issue with potential Francisella vaccines is strain phase variation to a gray form that lacks protective capability in...
Autores principales: | Soni, Shilpa, Ernst, Robert K., Muszyński, Artur, Mohapatra, Nrusingh P., Perry, Malcolm B., Vinogradov, Evgeny, Carlson, Russell W., Gunn, John S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Research Foundation
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3109528/ https://www.ncbi.nlm.nih.gov/pubmed/21687776 http://dx.doi.org/10.3389/fmicb.2010.00129 |
Ejemplares similares
-
Type A Francisella tularensis Acid Phosphatases Contribute to Pathogenesis
por: Mohapatra, Nrusingh P., et al.
Publicado: (2013) -
Regulation of Francisella Tularensis Virulence
por: Dai, Shipan, et al.
Publicado: (2011) -
Correction: Type A Francisella tularensis Acid Phosphatases Contribute to Pathogenesis
por: Mohapatra, Nrusingh P., et al.
Publicado: (2014) -
Unique Substrates Secreted by the Type VI Secretion System of Francisella tularensis during Intramacrophage Infection
por: Bröms, Jeanette E., et al.
Publicado: (2012) -
A Francisella tularensis Schu S4 Purine Auxotroph Is Highly Attenuated in Mice but Offers Limited Protection against Homologous Intranasal Challenge
por: Pechous, Roger D., et al.
Publicado: (2008)